These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 35977610)
1. Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!". Bowlus CL; Levy C; Hirschfield GM J Hepatol; 2022 Nov; 77(5):1452-1453. PubMed ID: 35977610 [No Abstract] [Full Text] [Related]
2. Seladelpar in patients with primary biliary cholangitis: Need for a closer look! Mishra AK; Singh SP J Hepatol; 2022 Nov; 77(5):1451. PubMed ID: 35594993 [No Abstract] [Full Text] [Related]
3. Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC). Wetten A; Jones DEJ; Dyson JK Expert Opin Investig Drugs; 2022 Oct; 31(10):1101-1107. PubMed ID: 36194037 [TBL] [Abstract][Full Text] [Related]
4. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Jones D; Boudes PF; Swain MG; Bowlus CL; Galambos MR; Bacon BR; Doerffel Y; Gitlin N; Gordon SC; Odin JA; Sheridan D; Wörns MA; Clark V; Corless L; Hartmann H; Jonas ME; Kremer AE; Mells GF; Buggisch P; Freilich BL; Levy C; Vierling JM; Bernstein DE; Hartleb M; Janczewska E; Rochling F; Shah H; Shiffman ML; Smith JH; Choi YJ; Steinberg A; Varga M; Chera H; Martin R; McWherter CA; Hirschfield GM Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):716-726. PubMed ID: 28818518 [TBL] [Abstract][Full Text] [Related]
5. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis. Kremer AE; Mayo MJ; Hirschfield G; Levy C; Bowlus CL; Jones DE; Steinberg A; McWherter CA; Choi YJ Liver Int; 2022 Jan; 42(1):112-123. PubMed ID: 34403559 [TBL] [Abstract][Full Text] [Related]
6. Reply to: "Chronic fatigue should not be overlooked in primary biliary cholangitis". Corpechot C J Hepatol; 2021 Sep; 75(3):745. PubMed ID: 34107290 [No Abstract] [Full Text] [Related]
7. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis. Buckley SE; DiPalma JA Am Fam Physician; 1996 Jan; 53(1):195-200. PubMed ID: 8546046 [TBL] [Abstract][Full Text] [Related]
9. Primary biliary cholangitis in a patient with metastatic breast cancer. Doello K; Rueda MT; Amezcua V Med Clin (Barc); 2021 Feb; 156(3):146. PubMed ID: 32107045 [No Abstract] [Full Text] [Related]
10. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis. O'Donohue J; Wong T; Portmann B; Williams R Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1143-50. PubMed ID: 12362106 [TBL] [Abstract][Full Text] [Related]
11. Changing Nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis". Tanaka A; Takikawa H; Mochida S; Koike K; Miwa H; Shimosegawa T J Gastroenterol; 2016 Jul; 51(7):748-9. PubMed ID: 27230619 [No Abstract] [Full Text] [Related]
12. Primary Hepatic Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient with Primary Biliary Cholangitis. Hamada K; Yamamoto S; Seno H Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e352-e353. PubMed ID: 33677076 [No Abstract] [Full Text] [Related]
13. Primary Biliary Cholangitis and Autoimmune Hepatitis. Gonzalez RS; Washington K Surg Pathol Clin; 2018 Jun; 11(2):329-349. PubMed ID: 29751878 [TBL] [Abstract][Full Text] [Related]